PharVision Advisers’s Alight ALIT Stock Holding History

PharVision Advisers’s Portfolio ALIT Stock Details ALIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,358	Closed	-$284K	–	682
2025 Q3	$284K	Buy	+4,358	New	+$385K	0.16%	260

Other funds holding ALIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannae Holdings Las Vegas, Nevada $134M AUM 85.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FNF

Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PharVision Advisers's ALIT Position: Q4 2025 in Review

PharVision Advisers sold out of Alight (ALIT) in Q4 2025, closing a stake of 4,358 shares — an estimated $284K sold.

PharVision Advisers first reported a position in ALIT in Q3 2025 and held it in 1 quarter. The position peaked at $284K in Q3 2025. 293 funds tracked by Wall St. Rank hold ALIT as of Q4 2025.

PharVision Advisers reported no remaining Alight position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 4,358 Alight shares in Q4 2025, an estimated $284K.
PharVision Advisers first reported a position in Alight in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Alight position peaked at $284K in Q3 2025.
293 funds tracked by Wall St. Rank held Alight as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.